The potential impact of post-COVID symptoms in the healthcare sector

被引:14
|
作者
Tempany, M. [1 ]
Leonard, A. [2 ,3 ,4 ]
Prior, A. R. [5 ]
Boran, G. [2 ,3 ,4 ]
Reilly, P. [2 ,3 ,4 ]
Murray, C. [2 ,3 ,4 ]
O'Brien, M. [2 ,3 ,4 ]
Maguire, G. [2 ,3 ,4 ]
Ennis, D. [2 ,3 ,4 ]
Rakovac, A. [2 ,3 ,4 ]
Reid, A. [1 ]
机构
[1] Tallaght Univ Hosp, Dept Occupat Hlth & Wellbeing, Dublin 24, Ireland
[2] Tallaght Univ Hosp, Dept Clin Chem, Dublin 24, Ireland
[3] Tallaght Univ Hosp, Dept Lab Med, Dublin 24, Ireland
[4] Trinity Coll Dublin, Sch Med, Dublin 2, Ireland
[5] Tallaght Univ Hosp, Dept Clin Microbiol, Dublin 24, Ireland
来源
OCCUPATIONAL MEDICINE-OXFORD | 2021年 / 71卷 / 6-7期
关键词
Healthcare worker; post-COVID syndrome; presenteeism; SARS-CoV-2; PRESENTEEISM; WORKERS;
D O I
10.1093/occmed/kqab109
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background The phenomenon of post-COVID syndrome (PCS) is evolving from an abstract array of non-specific symptoms to an identifiable clinical entity of variable severity. Its frequency and persistence have implications for service delivery and workforce planning. Aims This study was aimed to assess the prevalence of symptoms consistent with PCS and the subjective degree of recovery in a cohort of healthcare workers, focusing on those who have returned to work. Methods A study population of 1176 was surveyed when attending for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody testing. Two sub-groups were identified: those with known (i.e. diagnosed on PCR testing) and assumed (i.e. antibody evidence of previous infection) SARs-CoV-2 infection, at least 12 weeks prior to the study. Each group was asked about their subjective degree of recovery and the nature of their persistent symptoms. Results were analysed via excel and SPSS. Results In total, 144 employees showed PCR evidence of previous infection, with 139 of these being infected at least 12 weeks prior to the study. Of these 139, only 19% (n = 26) reported feeling 100% recovered, and 71% reported persistent symptoms. Of those with assumed SARS-CoV-2 infection (n = 78), 32 (41%) were truly asymptomatic since the commencement of the pandemic, while 46 (59%) described symptoms suggestive of possible infection at least 12 weeks prior to the study. Of this latter group, 23% (n = 18) also reported residual symptoms. Conclusions PCS is prevalent among this group, including those not previously diagnosed with COVID-19. Its' frequency and duration present challenges to employers with regards to the management of work availability and performance.
引用
收藏
页码:284 / 289
页数:6
相关论文
共 50 条
  • [41] Persistent IgG anticardiolipin autoantibodies are associated with post-COVID syndrome
    Bertin, Daniel
    Kaphan, Elsa
    Weber, Samuel
    Babacci, Benjamin
    Arcani, Robin
    Faucher, Benoit
    Menard, Amelie
    Brodovitch, Alexandre
    Mege, Jean Louis
    Bardin, Nathalie
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 113 : 23 - 25
  • [42] Predictors of post-COVID syndrome. Getting ready for the future
    Costa, Rita
    Esquinas, Antonio
    MONALDI ARCHIVES FOR CHEST DISEASE, 2023, 93 (03)
  • [43] Sleep Disorders in Post-COVID Syndrome: A Psychiatric or Neurological Problem?
    Kotova O.V.
    Medvedev V.E.
    Poluektov M.G.
    Belyaev A.A.
    Akarachkova E.S.
    Neuroscience and Behavioral Physiology, 2023, 53 (1) : 16 - 20
  • [44] NEUTROPHIL AND MONOCYTE EXTRACELLULAR TRAPS IN THE DIAGNOSIS OF POST-COVID SYNDROME
    Salmasi, J. M.
    Poryadin, G., V
    Panina, M., I
    Larina, V. N.
    Ryzhikh, A. A.
    Stodelova, E. A.
    Kazimirskii, A. N.
    BULLETIN OF RUSSIAN STATE MEDICAL UNIVERSITY, 2022, (06): : 80 - 84
  • [45] Autoantibodies in patients with post-COVID syndrome: a possible link with severity?
    Ceccarini, M. R.
    Bonetti, G.
    Medori, M. C.
    Dhuli, K.
    Tezzele, S.
    Micheletti, C.
    Maltese, P. E.
    Cecchin, S.
    Donato, K.
    Fioretti, F.
    Calzoni, A.
    Praderio, A.
    De Angelis, M. G.
    Nodari, S.
    Arabia, G.
    Lorusso, L.
    Beccari, T.
    Bertelli, M.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 : 48 - 56
  • [46] Portrait of mental health identified by people with the post-covid syndrome
    Mayo, Nancy E.
    Hum, Stanley
    Matout, Mohamad
    Fellows, Lesley K.
    Brouillette, Marie-Josee
    QUALITY OF LIFE RESEARCH, 2024, 33 (09) : 2509 - 2516
  • [47] The most common gastrointestinal alterations in patients with post-COVID syndrome
    Kata, Angyal
    Mandula, Tajthy Anna
    Balint, Dracz
    Pal, Miheller
    Miklos, Horvath
    Hajnal, Szekely
    Veronika, Papp
    Diana, Czompa
    Attila, Szijarto
    Klara, Werling
    ORVOSI HETILAP, 2023, 164 (31) : 1206 - 1212
  • [48] Post-COVID conditions-What practitioners need to know
    Waterbury, Susan
    NURSE PRACTITIONER, 2021, 46 (11) : 44 - 49
  • [49] Post-COVID Syndrome and Tachycardia: Theoretical Base and Treatment Experience
    Podzolkov, V., I
    Bragina, A. E.
    Tarzimanova, A., I
    Vasil'eva, L. V.
    Batrakova, E. P.
    Lobova, N., V
    Bykova, E. E.
    Khachuroeva, M. M.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2021, 17 (02) : 256 - 262
  • [50] Thiotriazolin effectiveness in complex treatment of patients with post-COVID syndrome
    Kryvenko, V., I
    Kolesnyk, M. Yu
    Bielenichev, I. F.
    Pavlov, S., V
    ZAPOROZHYE MEDICAL JOURNAL, 2021, 23 (03) : 402 - 411